statistiche ricercatore

Continente	#
NA - Nord America	840
EU - Europa	562
AS - Asia	407
SA - Sud America	52
AF - Africa	25
OC - Oceania	4
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.891

Nazione	#
US - Stati Uniti d'America	819
IT - Italia	228
SG - Singapore	122
CN - Cina	117
DE - Germania	62
HK - Hong Kong	55
SE - Svezia	54
GB - Regno Unito	52
RU - Federazione Russa	36
BR - Brasile	35
FI - Finlandia	30
FR - Francia	23
VN - Vietnam	22
IN - India	18
KR - Corea	16
ZA - Sudafrica	16
ID - Indonesia	15
CA - Canada	14
AR - Argentina	11
NL - Olanda	11
JP - Giappone	9
NO - Norvegia	9
TR - Turchia	9
PL - Polonia	8
LT - Lituania	7
BG - Bulgaria	6
ES - Italia	6
SI - Slovenia	6
CZ - Repubblica Ceca	5
MX - Messico	5
AU - Australia	4
CH - Svizzera	4
IQ - Iraq	4
PK - Pakistan	4
UA - Ucraina	4
UG - Uganda	4
AT - Austria	3
BE - Belgio	3
MY - Malesia	3
PH - Filippine	3
RO - Romania	3
UZ - Uzbekistan	3
MA - Marocco	2
PE - Perù	2
TW - Taiwan	2
A2 - ???statistics.table.value.countryCode.A2???	1
BD - Bangladesh	1
CL - Cile	1
CO - Colombia	1
DO - Repubblica Dominicana	1
EE - Estonia	1
EG - Egitto	1
GH - Ghana	1
IE - Irlanda	1
IR - Iran	1
LA - Repubblica Popolare Democratica del Laos	1
PA - Panama	1
PS - Palestinian Territory	1
SN - Senegal	1
TL - Timor Orientale	1
UY - Uruguay	1
VE - Venezuela	1
Totale	1.891

Nome	#
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency.	307
Voice assistance to develop a participatory research and action to improve health trajectories of people with PACS	294
Hypokalemia in Patients with COVID-19	266
Peritoneal dialysis in the time of coronavirus disease 2019	247
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia	224
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study	211
Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes.	184
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome.	178
Totale	1.911

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	127	0	0	0	0	0	14	14	9	9	17	31	33
2021/2022	265	17	25	15	10	12	9	27	24	30	19	47	30
2022/2023	267	29	37	27	16	30	21	17	23	32	4	16	15
2023/2024	260	4	19	25	25	27	24	29	41	12	15	19	20
2024/2025	510	20	12	8	31	81	81	52	32	53	30	41	69
2025/2026	453	73	58	85	103	119	15	0	0	0	0	0	0
Totale													1.911